Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

36.54 -0.14 (-0.38%)
Official Closing Price Updated: 8:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dimensional World ex U.S. Core Equity 2 ETF

< Previous 1 2 3 Next >
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report ↗
Via Stocktwits
Toyota Recalls Over Half A Million Vehicles In The US ↗
Via Stocktwits
Topics Product Recall
Ford Supplier Magna International Appoints Former Timken Executive As CFO ↗
Via Stocktwits
Topics Supply Chain
Stellantis Stock Slips After US Regulator Probes 287,000 Chrysler Minivans Over Concerns Regarding Electric Power Steer ↗
Via Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More ↗
Via Stocktwits
Citi Lowers Price Target On This Chinese EV Maker After Disappointing Q3 Guidance: Retail Expects Shares To ‘Eventually Implode’ ↗
Via Stocktwits
News headline image
Li Auto Announces Lower Q3 Delivery Outlook Despite New Vehicle Launches: Retail Sees i8, i6 Selling Like ‘Hot Cakes’ ↗
Li Auto now expects vehicle deliveries to be between 90,000 and 95,000 vehicles, representing a year-over-year decrease of 41.1% to 37.8%. 
Via Stocktwits
Topics Earnings
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More ↗
Via Stocktwits
Stellantis Shells Out $41M More To Expand Its U.S. Parts Distribution Network: More Details Inside ↗
Via Stocktwits
This Stock Just Got Downgraded By Macquarie On Rising Competition In Chinese Market – Do You Own It? ↗
Via Stocktwits
News headline image
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today? ↗
Novo Nordisk has entered into a collaboration with Replicate BioScience under which it will receive a defined, exclusive, worldwide license to use the latter’s self-replicating RNA platform to develop... 
Via Stocktwits
News headline image
OraSure Receives Warning From Ron Zwanziger: Entrepreneur Warns Of Adversarial Path If Board Continues To Refuse Buyout Offer ↗
Zwanziger made an unsolicited all-cash offer for the company earlier in the summer but was rebuffed. 
Via Stocktwits
News headline image
Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year ↗
Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark. 
Via Stocktwits
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death ↗
Via Stocktwits
News headline image
AstraZeneca Launches Home Delivery Service For Its Self-Administrable Flu Vaccine ↗
Flumist can be self-administered by adults 18 to 49 years of age or administered by a parent or caregiver to individuals 2-17 years of age. 
Via Stocktwits
Toyota Warns Higher US Tariff Impact For FY26: Retail Sees No Reason To Cheer ↗
Via Stocktwits
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence ↗
Via Stocktwits
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React ↗
Via Stocktwits
News headline image
Philips Plans $150M New Investments In US Manufacturing, R&D: Retail’s On The Fence ↗
The investment includes the expansion of the company’s Reedsville, PA, site and the recently announced expansion of the Image Guided Therapy facility in Plymouth, MN, the company said. 
Via Stocktwits
Topics Economy Government
News headline image
Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side ↗
UBS downgraded Novo Nordisk to ‘Neutral’ from ‘Buy’ with a price target of DKK 340, down from DKK 600. 
Via Stocktwits
News headline image
Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside ↗
Kruger’s position was newly created, and he will report to CEO Antonio Filosa. 
Via Stocktwits
Topics World Trade
News headline image
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability ↗
Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700. 
Via Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report ↗
Via Stocktwits
News headline image
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’ ↗
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
News headline image
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug ↗
The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%. 
Via Stocktwits
News headline image
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance ↗
A decision by the FDA on the new submission is expected in the first half of 2026. 
Via Stocktwits
News headline image
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe ↗
In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union. 
Via Stocktwits
News headline image
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants ↗
The company said that it now expects rapid approval for the treatment in eight African countries, including Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, Uganda, and Tanzania. 
Via Stocktwits
Topics Death Government
News headline image
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers ↗
The union expects the carmaker to produce 440,000 vehicles across its six assembly plants in Italy this year, including 250,000 passenger cars. 
Via Stocktwits
News headline image
US Regulator Initiates Recall Query Into Nearly 1.2M Stellantis Ram Trucks: Retail Sentiment Dips ↗
NHTSA said that it received 14 vehicle owner questionnaire reports and six death and injury reports under its Early Warning Reporting program describing failures of the Brake Transmission Shift... 
Via Stocktwits
Topics Product Recall
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.